Stay with the evidence, Pg6

Key Highlights:

• The Ministry of Health and Family Welfare has prohibited the manufacture, sale, and distribution of 16 Fixed Dose Combination (FDC) drugs for human use across India.
• The ban, effective immediately, was imposed under Section 26A of the Drugs and Cosmetics Act, 1940.
• The decision follows recommendations from an Expert Committee constituted by the Drugs Technical Advisory Board (DTAB), acting on directions from the Supreme Court.
• These FDCs were deemed to lack therapeutic justification, be irrational or unsafe, and pose potential health risks to patients.
• The banned drugs include categories such as dermatological preparations, analgesics, antispasmodics, and antibiotic-based formulations.

Detailed Insights:

• FDCs combine two or more active pharmacological ingredients in a fixed ratio within a single dosage form.
• They were originally intended to improve treatment compliance in chronic conditions like Tuberculosis by reducing pill burden.
• Irrational FDCs can be ineffective, counter-productive, and harmful, potentially leading to unnecessary side effects or difficulty in identifying the cause of allergic reactions.
• The use of irrational antibiotic FDCs significantly contributes to the growing problem of Antimicrobial Resistance (AMR) in the country.
• This is not the first such action; over 330 FDC drugs were banned in March 2016, and 205 FDCs between 2023 and 2025, for similar reasons.
• The Ministry of Health and Family Welfare has directed all State Drug Controllers, regulatory authorities, and enforcement agencies to ensure strict implementation of the ban.
• Manufacturers, importers, distributors, and pharmacies have been advised to stop stocking and selling the prohibited FDCs.
• The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, is responsible for regulating FDCs to ensure therapeutic rationality and patient safety.

Key Concepts Involved:

• Fixed Dose Combination (FDC) drugs: Pharmaceutical formulations containing two or more active ingredients in a fixed ratio within a single dosage form.
• Antimicrobial Resistance (AMR): Occurs when microorganisms evolve and no longer respond to medicines that once worked, making infections harder to treat.
• Drugs and Cosmetics Act, 1940: The primary legislation governing the manufacture, sale, and distribution of drugs and cosmetics in India.
• Drugs Technical Advisory Board (DTAB): A statutory body established under the Drugs and Cosmetics Act, 1940, providing technical and scientific advice to the central government on drug-related matters.